Removing One Barrier to Protecting Sex Partners in HIV Remission Studies With a Treatment Interruption

Only a few of the recommendations made in this supplement are implemented in ongoing HIV remission studies that involve an analytical treatment interruption. The absence of these recommendations in protocols puts sexual partners of study participants at serious risk. This paper addresses one possibl...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 220; no. Supplement_1; pp. S22 - S23
Main Author Eyal, Nir
Format Journal Article
LanguageEnglish
Published US Oxford University Press 02.07.2019
Subjects
Adult
Anti-HIV Agents - administration & dosage
Coinfection - prevention & control
Disease prevention
Drug dosages
Female
HIV
HIV Infections - prevention & control
HIV Infections - transmission
Human immunodeficiency virus
Humans
Male
Medical ethics
Medical research
Medical treatment
Remission
Remission (Medicine)
Remission Induction
Research ethics
Risk Factors
Sexual partners
Sexual Partners - psychology
Supplement
SUPPLEMENT ARTICLES
United States
Unsafe Sex - prevention & control
Vaccines - administration & dosage
Withholding Treatment
United States
clinical trials
HIV
human subject research
research ethics
analytic treatment interruption
HIV cure-related studies
Online AccessGet full text

Cover

More Information
Summary:Only a few of the recommendations made in this supplement are implemented in ongoing HIV remission studies that involve an analytical treatment interruption. The absence of these recommendations in protocols puts sexual partners of study participants at serious risk. This paper addresses one possible barrier to implementation: a certain misunderstanding among sponsors and research entities.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0022-1899
1537-6613
1537-6613
DOI:10.1093/infdis/jiz162